Fragment Informatics and Computational Fragment‐Based Drug Design: An Overview and Update

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 25,745 · see citing works

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139 · see citing works

Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy

Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0306430 · Cited by 10,057 · see citing works

Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening

Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030644s · Cited by 5,280 · see citing works

ZINC − A Free Database of Commercially Available Compounds for Virtual Screening

Irwin, J. J., & Shoichet, B. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049714+ · Cited by 4,058 · see citing works

Semianalytical treatment of solvation for molecular mechanics and dynamics

Still, W. C., Tempczyk, A., Hawley, R. C., & Hendrickson, T. F. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00172a038 · Cited by 3,653 · see citing works

A Fast Flexible Docking Method using an Incremental Construction Algorithm

Rarey, M., Kramer, B., Lengauer, T., & Klebe, G. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0477 · Cited by 2,836 · see citing works

Ant Algorithms for Discrete Optimization

Dorigo, M., Di, G. A., & Gambardella, L. M. (1999) · Artificial Life · doi:10.1162/106454699568728 · Cited by 2,812 · see citing works

A computational procedure for determining energetically favorable binding sites on biologically important macromolecules

Goodford, P. J. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00145a002 · Cited by 2,642 · see citing works

The Properties of Known Drugs. 1. Molecular Frameworks

Bemis, G. W., & Murcko, M. A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9602928 · Cited by 2,501 · see citing works

Free energy calculations: Applications to chemical and biochemical phenomena

Kollman, P. A. (1993) · Chemical Reviews · doi:10.1021/cr00023a004 · Cited by 2,131 · see citing works

Discovering High-Affinity Ligands for Proteins: SAR by NMR

Shuker, S. B., Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1996) · Science · doi:10.1126/science.274.5292.1531 · Cited by 2,045 · see citing works

Ligand efficiency: a useful metric for lead selection

Hopkins, A. L., Groom, C. R., & Alex, A. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03069-7 · Cited by 1,895 · see citing works

Rational design of potent sialidase-based inhibitors of influenza virus replication

von Itzstein, M., Wu, W.-Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Van Phan, T., Smythe, M. L., White, H. F., Oliver, S. W., et al. (1993) · Nature · doi:10.1038/363418a0 · Cited by 1,862 · see citing works

A ‘Rule of Three’ for fragment-based lead discovery?

Congreve, M., Carr, R. A. E., Murray, C. W., & Jhoti, H. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02831-9 · Cited by 1,365 · see citing works

Surflex: Fully Automatic Flexible Molecular Docking Using a Molecular Similarity-Based Search Engine

Jain, A. N. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020406h · Cited by 1,351 · see citing works

Molecular Hybridization: A Useful Tool in the Design of New Drug Prototypes

Viegas, C., Barreiro, E. J., & Fraga, C. A. M. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707781058805 · Cited by 1,314 · see citing works

Designed Multiple Ligands. An Emerging Drug Discovery Paradigm

Morphy, R., & Ranković, Z. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058225d · Cited by 1,237 · see citing works

A decade of fragment-based drug design: strategic advances and lessons learned

Hajduk, P. J., & Greer, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2220 · Cited by 1,068 · see citing works

Computer-based de novo design of drug-like molecules

Schneider, G., & Fechner, U. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1799 · Cited by 956 · see citing works

Hybrid Molecules with a Dual Mode of Action: Dream or Reality?

Meunier, B. (2007) · Accounts of Chemical Research · doi:10.1021/ar7000843 · Cited by 942 · see citing works

The computer program LUDI: A new method for the de novo design of enzyme inhibitors

B�hm, H.-J. (1992) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00124387 · Cited by 840 · see citing works

The rise of fragment-based drug discovery

Murray, C. W., & Rees, D. C. (2009) · Nature Chemistry · doi:10.1038/nchem.217 · Cited by 802 · see citing works

Fragment-based lead discovery

Rees, D. C., Congreve, M., Murray, C. W., & Carr, R. A. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1467 · Cited by 797 · see citing works

Computational Alanine Scanning To Probe Protein−Protein Interactions: A Novel Approach To Evaluate Binding Free Energies

Massova, I., & Kollman, P. A. (1999) · Journal of the American Chemical Society · doi:10.1021/ja990935j · Cited by 778 · see citing works

“Scaffold-Hopping” by Topological Pharmacophore Search: A Contribution to Virtual Screening

Schneider, G., Neidhart, W. L., Giller, T., & Schmid, G. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19991004)38:19 · Cited by 715 · see citing works

RECAPRetrosynthetic Combinatorial Analysis Procedure: A Powerful New Technique for Identifying Privileged Molecular Fragments with Useful Applications in Combinatorial Chemistry

Lewell, X. Q., Judd, D. B., Watson, S. P., & Hann, M. M. (1998) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci970429i · Cited by 695 · see citing works

Novel trends in high-throughput screening

Mayr, L. M., & Bojanic, D. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.08.004 · Cited by 690 · see citing works

Structure of Nitric Oxide Synthase Oxygenase Dimer with Pterin and Substrate

Crane, B. R., Arvai, A. S., Ghosh, D. K., Wu, C., Getzoff, E. D., Stuehr, D. J., & Tainer, J. A. (1998) · Science · doi:10.1126/science.279.5359.2121 · Cited by 668 · see citing works

Prediction of Protein−Ligand Interactions. Docking and Scoring: Successes and Gaps

Leach, A. R., Shoichet, B. K., & Peishoff, C. E. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060999m · Cited by 648 · see citing works

Crystal Structure of Constitutive Endothelial Nitric Oxide Synthase

Raman, C. S., Li, H., Pavel Martasek, E., Král, V., Masters, B. S. S., & Poulos, T. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81718-3 · Cited by 621 · see citing works

Recent Developments in Fragment-Based Drug Discovery

Congreve, M., Chessari, G., Tisi, D., & Woodhead, A. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8000373 · Cited by 613 · see citing works

Functionality maps of binding sites: A multiple copy simultaneous search method

Miranker, A. D., & Karplus, M. (1991) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340110104 · Cited by 546 · see citing works

Pursuing the leadlikeness concept in pharmaceutical research

Hann, M. M., & Oprea, T. I. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.04.003 · Cited by 516 · see citing works

Assessing Scoring Functions for Protein−Ligand Interactions

Ferrara, P., Gohlke, H., Price, D. J., Klebe, G., & Brooks, C. L. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030489h · Cited by 481 · see citing works

Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation.

Fischmann, T. O., Hruza, A. W., Niu, X. D., Fossetta, J. D., Lunn, C. A., Dolphin, E., Prongay, A., Reichert, P., Lundell, D. J., Narula, S. K., et al. (1999) · Nature Structural Biology · doi:10.1038/6675 · Cited by 463 · see citing works

Fragment-Based Lead Discovery Using X-ray Crystallography

Hartshorn, M. J., Murray, C. W., Cleasby, A., Frederickson, M., Tickle, I. J., & Jhoti, H. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0495778 · Cited by 425 · see citing works

Optimizing Fragment and Scaffold Docking by Use of Molecular Interaction Fingerprints

Marcou, G., & Rognan, D. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci600342e · Cited by 404 · see citing works

Tethering: Fragment-Based Drug Discovery

Erlanson, D. A., Wells, J. A., & Braisted, A. C. (2004) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.33.110502.140409 · Cited by 385 · see citing works

The Scaffold Tree − Visualization of the Scaffold Universe by Hierarchical Scaffold Classification

Schuffenhauer, A., Ertl, P., Roggo, S. P., Wetzel, S., Koch, М. A., & Waldmann, H. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci600338x · Cited by 365 · see citing works

Fragment-based lead discovery: leads by design

Carr, R. A. E., Congreve, M., Murray, C. W., & Rees, D. C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03511-7 · Cited by 343 · see citing works

Feature trees: A new molecular similarity measure based on tree matching

Rarey, M., & Dixon, J. S. (1998) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008068904628 · Cited by 329 · see citing works

Theory and Applications of NMR-Based Screening in Pharmaceutical Research

Lepre, C. A., Moore, J. M., & Peng, J. W. (2004) · Chemical Reviews · doi:10.1021/cr030409h · Cited by 323 · see citing works

Cheminformatics Analysis of Organic Substituents: Identification of the Most Common Substituents, Calculation of Substituent Properties, and Automatic Identification of Drug-like Bioisosteric Groups

Ertl, P. (2002) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0255782 · Cited by 294 · see citing works

LigBuilder: A Multi-Purpose Program for Structure-Based Drug Design

Wang, R., Gao, Y. D., & Lai, L. (2000) · Journal of Molecular Modeling · doi:10.1007/s0089400060498 · Cited by 293 · see citing works

Scaffold Architecture and Pharmacophoric Properties of Natural Products and Trade Drugs: Application in the Design of Natural Product-Based Combinatorial Libraries

Lee, M., & Schneider, G. (2001) · Journal of Combinatorial Chemistry · doi:10.1021/cc000097l · Cited by 291 · see citing works

On the nature of cavities on protein surfaces: Application to the identification of drug‐binding sites

Nayal, M., & Honig, B. H. (2006) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20897 · Cited by 285 · see citing works

Properties of Known Drugs. 2. Side Chains

Bemis, G. W., & Murcko, M. A. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9903996 · Cited by 280 · see citing works

The SHAPES strategy: an NMR-based approach for lead generation in drug discovery

Fejzo, J., Lepre, C. A., Peng, J. W., Bemis, G. W., Ajay, Murcko, M. A., & Moore, J. M. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(00)80022-8 · Cited by 276 · see citing works

CAVEAT: A program to facilitate the design of organic molecules

Lauri, G., & Bartlett, P. A. (1994) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00124349 · Cited by 268 · see citing works

SMoG: de Novo Design Method Based on Simple, Fast, and Accurate Free Energy Estimates. 1. Methodology and Supporting Evidence

DeWitte, R. S., & Shakhnovich, E. I. (1996) · Journal of the American Chemical Society · doi:10.1021/ja960751u · Cited by 264 · see citing works

Locating and characterizing binding sites on proteins

Mattos, C., & Ringe, D. (1996) · Nature Biotechnology · doi:10.1038/nbt0596-595 · Cited by 256 · see citing works

De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks

Schneider, G., Lee, M., Ståhl, M., & Schneider, P. (2000) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008184403558 · Cited by 252 · see citing works

Computer design of bioactive molecules: A method for receptor‐based de novo ligand design

Moon, J. B., & Howe, W. J. (1991) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340110409 · Cited by 228 · see citing works

Route Designer: A Retrosynthetic Analysis Tool Utilizing Automated Retrosynthetic Rule Generation

Law, J. B., Zsoldos, Z., Simon, A., Reid, D., Liu, Y., Khew, S. Y., Johnson, A. P., Major, S., Wade, R. A., & Ando, H. Y. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci800228y · Cited by 228 · see citing works

Interactive exploration of chemical space with Scaffold Hunter

Wetzel, S., Klein, K., Renner, S., Rauh, D., Oprea, T. I., Mutzel, P., & Waldmann, H. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.187 · Cited by 227 · see citing works

SYNOPSIS: SYNthesize and OPtimize System in Silico

Vinkers, H. M., de Jonge, M. R., Daeyaert, F. F. D., Heeres, J., Koymans, L. M. H., van Lenthe, J. H., Lewi, P. J., Timmerman, H., Aken, K. V., & Janssen, P. A. J. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030809x · Cited by 225 · see citing works

A Three-Dimensional Model of Lanosterol 14α-Demethylase of Candida albicans and Its Interaction with Azole Antifungals

Ji, H., Zhang, W., Zhou, Y., Zhang, M., Zhu, J. S., Song, Y., Lü, J., & Zhu, J. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990589g · Cited by 213 · see citing works

A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design

Card, G. L., Blasdel, L. K., England, B. P., Zhang, C., Suzuki, Y., Gillette, S., Fong, D., Ibrahim, P. N., Artis, D. R., Bollag, G. E., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1059 · Cited by 208 · see citing works

From fragment to clinical candidate—a historical perspective

Chessari, G., & Woodhead, A. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.04.007 · Cited by 203 · see citing works

Library Design for Fragment Based Screening

Schuffenhauer, A., Rüdisser, S., Marzinzik, A. L., Jahnke, W., Selzer, P. M., & Jacoby, E. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026054637700 · Cited by 203 · see citing works

LigBuilder 2: A Practical de Novo Drug Design Approach

Yuan, Y., Pei, J., & Lai, L. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci100350u · Cited by 199 · see citing works

Ligand binding: functional site location, similarity and docking

Campbell, S. J., Gold, N. D., Jackson, R. M., & Westhead, D. R. (2003) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(03)00075-7 · Cited by 199 · see citing works

Ligand efficiency and fragment-based drug discovery

Bembenek, S. D., Tounge, B. A., & Reynolds, C. H. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.11.007 · Cited by 196 · see citing works

GroupBuild: a fragment-based method for de novo drug design

Rotstein, S. H., & Murcko, M. A. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00064a003 · Cited by 195 · see citing works

Predicting aqueous solubility from structure

Delaney, J. S. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03365-3 · Cited by 192 · see citing works

SPR-based Fragment Screening: Advantages and Applications

Neumann, T., Junker, H.-D., Schmidt, K., & Sekul, R. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607782341073 · Cited by 190 · see citing works

BREED: Generating Novel Inhibitors through Hybridization of Known Ligands. Application to CDK2, P38, and HIV Protease

Pierce, A. C., Rao, G., & Bemis, G. W. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030543u · Cited by 189 · see citing works

Multiple Highly Diverse Structures Complementary to Enzyme Binding Sites: Results of Extensive Application of a de Novo Design Method Incorporating Combinatorial Growth

Bohacek, R. S., & McMartin, C. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00092a006 · Cited by 189 · see citing works

Structure-Based Optimization of Azole Antifungal Agents by CoMFA, CoMSIA, and Molecular Docking

Sheng, C., Zhang, W., Ji, H., Zhang, M., Song, Y., Xu, H., Zhu, J. S., Miao, Z., Jiang, Q., Yao, J., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051211n · Cited by 188 · see citing works

Docking, virtual high throughput screening and in silico fragment‐based drug design

Zoete, V., Grosdidier, A., & Michielin, O. A. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00665.x · Cited by 186 · see citing works

Recognition of Privileged Structures by G-Protein Coupled Receptors

Bondensgaard, K., Ankersen, M., Thøgersen, H., Hansen, B. S., Wulff, B. S., & Bywater, R. P. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0309452 · Cited by 182 · see citing works

SPROUT: Recent developments in the de novo design of molecules

Gillet, V. J., Newell, W. R., Mata, P., Myatt, G. J., Sike, S., Zsoldos, Z., & Johnson, A. P. (1994) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00017a027 · Cited by 179 · see citing works

Methods for the Prediction of Protein-Ligand Binding Sites for Structure-Based Drug Design and Virtual Ligand Screening.

Publisher, B. S. P. B. S. (2006) · Current Protein and Peptide Science · doi:10.2174/138920306778559386 · Cited by 178 · see citing works

Structure and reaction based evaluation of synthetic accessibility

Boda, K., Seidel, T., & Gasteiger, J. (2007) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-006-9099-2 · Cited by 178 · see citing works

Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-d]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone

Brough, P. A., Barril, X., Borgognoni, J., Chêne, P., Davies, N. G. M., Davis, B. J., Drysdale, M. J., Dymock, B. W., Eccles, S. A., Garcı́a-Echeverrı́a, C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900357y · Cited by 175 · see citing works

Exhaustive docking of molecular fragments with electrostatic solvation

Majeux, N., Scarsi, M., Apostolakis, J., Ehrhardt, C., & Caflisch, A. (1999) · Proteins Structure Function and Bioinformatics · doi:10.1002/(sici)1097-0134(19991001)37:1 · Cited by 175 · see citing works

High-throughput drug discovery: What can we expect from HTS?

Gribbon, P. M., & Andreas, S. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03275-1 · Cited by 173 · see citing works

Computational approaches to determine drug solubility

Faller, B., & Ertl, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.005 · Cited by 173 · see citing works

Scaffold composition and biological relevance of screening libraries

Shelat, A. A., & Guy, R. K. (2007) · Nature Chemical Biology · doi:10.1038/nchembio0807-442 · Cited by 167 · see citing works

The Most Common Chemical Replacements in Drug-Like Compounds

Sheridan, R. P. (2002) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0100806 · Cited by 167 · see citing works

Deconstructing fragment-based inhibitor discovery

Babaoglu, K., & Shoichet, B. K. (2006) · Nature Chemical Biology · doi:10.1038/nchembio831 · Cited by 166 · see citing works

De Novo Drug Design

Hartenfeller, M., & Schneider, G. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-839-3_12 · Cited by 160 · see citing works

New Lead Structures in Antifungal Drug Discovery

Sheng, C., & Zhang, W. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711794480113 · Cited by 159 · see citing works

Multiple Solvent Crystal Structures: Probing Binding Sites, Plasticity and Hydration

Mattos, C., Bellamacina, C. R., Peisach, E., Pereira, A., Vitkup, D., Petsko, G. A., & Ringe, D. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.01.039 · Cited by 153 · see citing works

Similarity searching in large combinatorial chemistry spaces

Rarey, M., & Ståhl, M. (2001) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1011144622059 · Cited by 150 · see citing works

Vemurafenib

Flaherty, K. T., Yasothan, U., & Kirkpatrick, P. N. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3579 · Cited by 148 · see citing works

SAR by MS: A Ligand Based Technique for Drug Lead Discovery Against Structured RNA Targets

Swayze, E. E., Jefferson, E. A., Sannes, K. A., Blyn, L. B., Risen, L. M., Arakawa, S., Osgood, S. A., Hofstadler, S. A., & Griffey, R. H. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0255466 · Cited by 145 · see citing works

Parameter Estimation for Scoring Protein−Ligand Interactions Using Negative Training Data

Pham, T. A., & Jain, A. N. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050040j · Cited by 145 · see citing works

Evolutionary algorithms in computer-aided molecular design

Clark, D. E., & Westhead, D. R. (1996) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00124503 · Cited by 145 · see citing works

Fragment-Based de Novo Ligand Design by Multiobjective Evolutionary Optimization

Dey, F., & Caflisch, A. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci700424b · Cited by 144 · see citing works

Integration of fragment screening and library design

Siegal, G., Eiso, A. B., & Schultz, J. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.08.005 · Cited by 142 · see citing works

Recore: A Fast and Versatile Method for Scaffold Hopping Based on Small Molecule Crystal Structure Conformations

Maaß, P. C., Schulz‐Gasch, T., Ståhl, M., & Rarey, M. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci060094h · Cited by 141 · see citing works

Bioactivity-guided mapping and navigation of chemical space

Renner, S., van Otterlo, W. A. L., Domínguez, M., Möcklinghoff, S., Hofmann, B., Wetzel, S., Schuffenhauer, A., Ertl, P., Oprea, T. I., Steinhilber, D., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.188 · Cited by 141 · see citing works

Design of Selective Neuronal Nitric Oxide Synthase Inhibitors for the Prevention and Treatment of Neurodegenerative Diseases

Silverman, R. B. (2009) · Accounts of Chemical Research · doi:10.1021/ar800201v · Cited by 133 · see citing works

Properties and Architecture of Drugs and Natural Products Revisited

Grabowski, K., & Schneider, G. (2007) · Current Chemical Biology · doi:10.2174/2212796810701010115 · Cited by 132 · see citing works

Docking Performance of Fragments and Druglike Compounds

Verdonk, M. L., Giangreco, I., Hall, R. J., Korb, O., Mortenson, P. N., & Murray, C. W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200558u · Cited by 130 · see citing works

Virtual Fragment Docking by Glide: a Validation Study on 190 Protein−Fragment Complexes

Sándor, M., Kiss, R., & Keserű, G. M. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci1000407 · Cited by 129 · see citing works

On the use of LUDI to search the Fine Chemicals Directory for ligands of proteins of known three-dimensional structure

B�hm, H.-J. (1994) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00123669 · Cited by 128 · see citing works

De Novo Drug Design Using Multiobjective Evolutionary Graphs

Nicolaou, C. A., Apostolakis, J., & Pattichis, C. S. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci800308h · Cited by 121 · see citing works

Discovery of Cyclic Acylguanidines as Highly Potent and Selective β-Site Amyloid Cleaving Enzyme (BACE) Inhibitors: Part I—Inhibitor Design and Validation

Zhu, Z., Sun, Z. J., Ye, Y., Voigt, J. H., Strickland, C., Smith, E. M., Cumming, J. N., Wang, L., Wong, J. K. Y., Wang, Y., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901408p · Cited by 121 · see citing works

Identification and mapping of small-molecule binding sites in proteins: computational tools for structure-based drug design

Sotriffer, C., & Klebe, G. (2002) · Il Farmaco · doi:10.1016/s0014-827x(02)01211-9 · Cited by 121 · see citing works

Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography

Davies, D. R., Mamat, B., Magnússon, Ó. Þ., Christensen, J., Haraldsson, M. H., Mishra, R. K., Pease, B., Hansen, E., Singh, J., Zembower, D. E., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900259h · Cited by 119 · see citing works

Computational approaches for fragment-based and de novo design.

Loving, K., Alberts, I., & Sherman, W. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610790232305 · Cited by 118 · see citing works

Drug and Drug Candidate Building Block Analysis

Wang, J., & Hou, T. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900398f · Cited by 118 · see citing works

Impact of linker strain and flexibility in the design of a fragment-based inhibitor

Chung, S., Parker, J. B., Bianchet, M. A., Amzel, L. M., & Stivers, J. T. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.163 · Cited by 118 · see citing works

The Novel Binding Mode of N-Alkyl-N‘-hydroxyguanidine to Neuronal Nitric Oxide Synthase Provides Mechanistic Insights into NO Biosynthesis

Li, H., Shimizu, H., Flinspach, M. L., Jamal, J., Yang, W., Xian, M., Cai, T., Wen, E. Z., Jia, Q., Wang, P. G., et al. (2002) · Biochemistry · doi:10.1021/bi020417c · Cited by 116 · see citing works

Three-Dimensional Model of Lanosterol 14α-Demethylase from Cryptococcus neoformans : Active-Site Characterization and Insights into Azole Binding

Sheng, C., Miao, Z., Ji, H., Yao, J., Wang, W., Che, X., Dong, G., Lü, J., Guo, W. P., & Zhang, W. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01630-08 · Cited by 113 · see citing works

AutoGrow: A Novel Algorithm for Protein Inhibitor Design

Durrant, J. D., Amaro, R. E., & McCammon, J. A. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00761.x · Cited by 113 · see citing works

CONCERTS: Dynamic Connection of Fragments as an Approach to de Novo Ligand Design

Pearlman, D. A., & Murcko, M. A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950792l · Cited by 111 · see citing works

Flux (1): A Virtual Synthesis Scheme for Fragment-Based de Novo Design

Fechner, U., & Schneider, G. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci0503560 · Cited by 108 · see citing works

Automated site-directed drug design: a general algorithm for knowledge acquisition about hydrogen-bonding regions at protein surfaces

Danziger, D. J., & Dean, P. M. (1989) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1989.0015 · Cited by 106 · see citing works

Fragonomics: fragment-based drug discovery

Zartler, E. R., & Shapiro, M. J. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.05.002 · Cited by 104 · see citing works

Docking for fragment inhibitors of AmpC β-lactamase

Teotico, D. G., Babaoglu, K., Rocklin, G. J., Ferreira, R. S., Giannetti, A. M., & Shoichet, B. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813029106 · Cited by 102 · see citing works

Grand Canonical Monte Carlo Simulation of Ligand−Protein Binding

Clark, M., Guarnieri, F., Shkurko, I., & Wiseman, J. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci050268f · Cited by 102 · see citing works

HierS: Hierarchical Scaffold Clustering Using Topological Chemical Graphs

Wilkens, S. J., Janes, J. O., & Su, A. I. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049032d · Cited by 102 · see citing works

Are Target-Family-Privileged Substructures Truly Privileged?

Schnur, D. M., Hermsmeier, M. A., & Tebben, A. J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0502900 · Cited by 101 · see citing works

Minimal Pharmacophoric Elements and Fragment Hopping, an Approach Directed at Molecular Diversity and Isozyme Selectivity. Design of Selective Neuronal Nitric Oxide Synthase Inhibitors

Ji, H., Stanton, B. Z., Igarashi, J., Li, H., Pavel Martasek, E., Roman, L. J., Poulos, T. L., & Silverman, R. B. (2008) · Journal of the American Chemical Society · doi:10.1021/ja0772041 · Cited by 99 · see citing works

Structure-Based de Novo Design, Synthesis, and Biological Evaluation of Non-Azole Inhibitors Specific for Lanosterol 14α-Demethylase of Fungi

Ji, H., Zhang, W., Zhang, M., Kudo, M., Aoyama, Y., Yoshida, Y., Sheng, C., Song, Y., Yang, S., Zhou, Y., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020362c · Cited by 99 · see citing works

Virtual fragment screening: an exploration of various docking and scoring protocols for fragments using Glide

Kawatkar, S. P., Wang, H., Czermiński, R., & Joseph‐McCarthy, D. (2009) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-009-9281-4 · Cited by 98 · see citing works

Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy

Chen, H., Gao, J., Lu, Y., Kou, G., Zhang, H., Fan, L., Sun, Z., Guo, Y., & Zhong, Y. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.010 · Cited by 97 · see citing works

The NEWLEAD program: a new method for the design of candidate structures from pharmacophoric hypotheses

Tschinke, V., & Cohen, N. C. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00076a016 · Cited by 97 · see citing works

Efficient electrostatic solvation model for protein-fragment docking

Majeux, N., Scarsi, M., & Caflisch, A. (2000) · Proteins Structure Function and Bioinformatics · doi:10.1002/1097-0134(20010201)42:2 · Cited by 97 · see citing works

Cyclophilin A - Promising New Target in Cardiovascular Therapy -

Satoh, K., Shimokawa, H., & Berk, B. C. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0904 · Cited by 96 · see citing works

Discovering Potent Small Molecule Inhibitors of Cyclophilin A Using de Novo Drug Design Approach

Ni, S., Yuan, Y., Huang, J. Y., Mao, X., Lv, M., Zhu, J., Shen, X., Pei, J., Lai, L., Jiang, H., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9008295 · Cited by 96 · see citing works

Similarity Searching and Scaffold Hopping in Synthetically Accessible Combinatorial Chemistry Spaces

Boehm, M., Wu, T.-Y., Claussen, H., & Lemmen, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm0707727 · Cited by 96 · see citing works

Thermodynamic cycle integration by computer simulation as a tool for obtaining free energy differences in molecular chemistry

van Gunsteren, W. F., & Berendsen, H. J. C. (1987) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf01676960 · Cited by 94 · see citing works

Searching Fragment Spaces with Feature Trees

Lessel, U. F., Wellenzohn, B., Lilienthal, M., & Claussen, H. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci800272a · Cited by 92 · see citing works

De novodesign: balancing novelty and confined chemical space

Kutchukian, P. S., & Shakhnovich, E. I. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2010.497534 · Cited by 92 · see citing works

An automated method for dynamic ligand design

Miranker, A. D., & Karplus, M. (1995) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340230403 · Cited by 91 · see citing works

Discovery of Highly Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase by Fragment Hopping

Ji, H., Li, H., Pavel Martasek, E., Roman, L. J., Poulos, T. L., & Silverman, R. B. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801220a · Cited by 90 · see citing works

Free energies of binding of polychlorinated biphenyls to the estrogen receptor from a single simulation

Oostenbrink, C., & A, W. F. V. G. (2003) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.10558 · Cited by 89 · see citing works

Fragment-Based Drug Design and Drug Repositioning Using Multiple Ligand Simultaneous Docking (MLSD): Identifying Celecoxib and Template Compounds as Novel Inhibitors of Signal Transducer and Activator of Transcription 3 (STAT3)

Li, H., Liu, A., Zhao, Z., Xu, Y. F., Lin, J., Jou, D., & Li, C. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101330h · Cited by 85 · see citing works

FEP-Guided Selection of Bicyclic Heterocycles in Lead Optimization for Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase

Kim, J. T., Hamilton, A. D., Bailey, C. M., Domoal, R. A., Wang, L., Anderson, K. S., & Jorgensen, W. L. (2006) · Journal of the American Chemical Society · doi:10.1021/ja066472g · Cited by 85 · see citing works

Topomers: A Validated Protocol for Their Self-Consistent Generation

Jilek, R. J., & CRAMER, R. D. I. (2004) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci049961d · Cited by 85 · see citing works

Detection of ligand binding hot spots on protein surfaces via fragment-based methods: application to DJ-1 and glucocerebrosidase

Landon, M. R., Lieberman, R. L., Hoang, Q. Q., Ju, S., Caaveiro, J. M. M., Orwig, S. D., Kozakov, D., Brenke, R., Chuang, G., Beglov, D., et al. (2009) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-009-9283-2 · Cited by 84 · see citing works

In Silico Prediction of Binding Sites on Proteins

Leis, S., Schneider, S., & Zacharias, M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790979944 · Cited by 84 · see citing works

Substructure Mining Using Elaborate Chemical Representation

Kazius, J., Nijssen, S., Kok, J. N., Bäck, T., & IJzerman, A. P. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci0503715 · Cited by 83 · see citing works

The SuMo server: 3D search for protein functional sites

Jambon, M., Andrieu, O., Combet, C., Deléage, G., Delfaud, F., & Geourjon, C. (2005) · Computer applications in the biosciences · doi:10.1093/bioinformatics/bti645 · Cited by 83 · see citing works

Cyclophilin A: potential functions and therapeutic target for human cancer.

Obchoei, S., Wongkhan, S., Wongkham, C., Li, M., Yao, Q. C., & Chen, C. (2009) · PubMed · Cited by 82 · see citing works

Knowledge-Based Approach to <i>de Novo</i> Design Using Reaction Vectors

Patel, H., Bodkin, M. J., Chen, B., & Gillet, V. J. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci800413m · Cited by 82 · see citing works

A validation study on the practical use of automated de novo design

Ståhl, M., Todorov, N. P., James, T., Mauser, H., Boehm, H.-J., & Dean, P. M. (2002) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1021242018286 · Cited by 79 · see citing works

Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy

Ji, H., Tan, S., Igarashi, J., Li, H., Derrick, M., Pavel Martasek, E., Roman, L. J., Vasquez-Vivar, J. M., Poulos, T. L., & Silverman, R. B. (2009) · Annals of Neurology · doi:10.1002/ana.21555 · Cited by 78 · see citing works

BUILDER v.2: Improving the chemistry of a de novo design strategy

Roe, D. C., & Kuntz, I. D. (1995) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00124457 · Cited by 78 · see citing works

Toward General Methods of Targeted Library Design: Topomer Shape Similarity Searching with Diverse Structures as Queries

Andrews, K. M., & CRAMER, R. D. I. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000003m · Cited by 78 · see citing works

Voyages to the (un)known: adaptive design of bioactive compounds

Schneider, G., Hartenfeller, M., Reutlinger, M., Tanrikulu, Y., Proschak, E., & Schneider, P. (2008) · Trends in biotechnology · doi:10.1016/j.tibtech.2008.09.005 · Cited by 77 · see citing works

Drugs in other drugs: a new look at drugs as fragments

Siegel, M. G., & Vieth, M. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.11.011 · Cited by 76 · see citing works

Application of Fragment-Based Drug Discovery to Membrane Proteins: Identification of Ligands of the Integral Membrane Enzyme DsbB

Früh, V., Zhou, Y., Chen, D., Loch, C., Eiso, A. B., Grinkova, Y. N., Verheij, H. J., Sligar, S. G., Bushweller, J. H., & Siegal, G. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.06.011 · Cited by 76 · see citing works

Flaviviral Protease Inhibitors Identified by Fragment-Based Library Docking into a Structure Generated by Molecular Dynamics

Ekonomiuk, D., Su, X., Ozawa, K., Bodenreider, C., Lim, S. P., Otting, G., Danzhi Huang, A., & Caflisch, A. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900448m · Cited by 75 · see citing works

FlexNovo : Structure‐Based Searching in Large Fragment Spaces

Degen, J., & Rarey, M. (2006) · ChemMedChem · doi:10.1002/cmdc.200500102 · Cited by 72 · see citing works

New azoles with potent antifungal activity: Design, synthesis and molecular docking

Che, X., Sheng, C., Wang, W., Cao, Y., Xu, Y., Ji, H., Dong, G., Miao, Z., Yao, J., & Zhang, W. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.05.018 · Cited by 71 · see citing works

Fragment Library Screening and Lead Characterization Using SPR Biosensors

Danielson, U. H. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609790102392 · Cited by 70 · see citing works

Selectivity of Kinase Inhibitor Fragments

Bamborough, P., Brown, M. J. B., Christopher, J. A., Chung, C., & Mellor, G. W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200349b · Cited by 70 · see citing works

SMoG: de Novo Design Method Based on Simple, Fast, and Accurate Free Energy Estimates. 2. Case Studies in Molecular Design

DeWitte, R. S., Ishchenko, A. V., & Shakhnovich, E. I. (1997) · Journal of the American Chemical Society · doi:10.1021/ja963689+ · Cited by 69 · see citing works

Concept of Combinatorial De Novo Design of Drug‐like Molecules by Particle Swarm Optimization

Hartenfeller, M., Proschak, E., Schüller, A., & Schneider, G. (2008) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00672.x · Cited by 69 · see citing works

FOG: Fragment Optimized Growth Algorithm for the de Novo Generation of Molecules Occupying Druglike Chemical Space

Kutchukian, P. S., Lou, D., & Shakhnovich, E. I. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci9000458 · Cited by 69 · see citing works

PhDD: A new pharmacophore-based de novo design method of drug-like molecules combined with assessment of synthetic accessibility

Huang, Q., Li, L., & Yang, S. (2010) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2010.02.002 · Cited by 69 · see citing works

Computational intelligence approaches for pattern discovery in biological systems

Fogel, G. B. (2008) · Briefings in Bioinformatics · doi:10.1093/bib/bbn021 · Cited by 69 · see citing works

Chemical Fragments as Foundations for Understanding Target Space and Activity Prediction

Sutherland, J. J., Higgs, R. E., Watson, I., & Vieth, M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701399f · Cited by 68 · see citing works

SVM Model for Virtual Screening of Lck Inhibitors

Liew, C. Y., Ma, X. H., Liu, X., & Yap, C. W. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci800387z · Cited by 66 · see citing works

Flux (2): Comparison of Molecular Mutation and Crossover Operators for Ligand-Based de Novo Design

Fechner, U., & Schneider, G. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci6005307 · Cited by 66 · see citing works

Chemical Fragment Spaces for de novo Design

Mauser, H., & Ståhl, M. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci6003652 · Cited by 65 · see citing works

Multiple ligand simultaneous docking: Orchestrated dancing of ligands in binding sites of protein

Li, H., & Li, C. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21486 · Cited by 64 · see citing works

Homology Modeling of Lanosterol 14α-Demethylase ofCandida albicansandAspergillus fumigatusand Insights into the Enzyme-Substrate Interactions

Sheng, C., Zhang, W., Zhang, M., Song, Y., Ji, H., Zhu, J. S., Yao, J., Yu, J. A., Yang, S., Zhou, Y., et al. (2004) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2004.10506984 · Cited by 63 · see citing works

The first de novo designed inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase

Heikkila, T., Thirumalairajan, S., Davies, M., Parsons, M. R., McConkey, G. A., Fishwick, C. W. G., & Johnson, A. P. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.09.045 · Cited by 63 · see citing works

Design and synthesis of antifungal benzoheterocyclic derivatives by scaffold hopping

Sheng, C., Che, X., Wang, W., Wang, S., Cao, Y., Yao, J., Miao, Z., & Zhang, W. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.01.075 · Cited by 62 · see citing works

Informatics and modeling challenges in fragment-based drug discovery.

Hubbard, R. E., Chen, I., & Davis, B. J. (2007) · PubMed · Cited by 61 · see citing works

Synthesis and Antifungal Activities of Novel 2-Aminotetralin Derivatives

Bin, Y., Ji, H., Cao, Y., Zhou, Y., Zhu, J., Lü, J., Li, Y., Chen, J., Zheng, C., Jiang, Y., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0701167 · Cited by 59 · see citing works

The multiple roles of computational chemistry in fragment-based drug design

Law, R., Barker, O., Barker, J. J., Hesterkamp, T., Godemann, R., Andersen, O. A., Fryatt, T., Courtney, S., Hallett, D., & Whittaker, M. A. (2009) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-009-9284-1 · Cited by 57 · see citing works

Structure-guided fragment-based in silico drug design of dengue protease inhibitors

Knehans, T., Schüller, A., Doan, D. N. P., Nacro, K., Hill, J., Güntert, P., Madhusudhan, M. S., Weil, T., & Vasudevan, S. G. (2011) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9418-0 · Cited by 57 · see citing works

Detection and Assignment of Common Scaffolds in Project Databases of Lead Molecules

Clark, A. M., & Labute, P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801098a · Cited by 56 · see citing works

Structure-Based Design, Synthesis, and Biological Evaluation of Novel Inhibitors of Human Cyclophilin A

Guichou, J., Viaud, J., Mettling, C., Subra, G., Lin, Y., & Chavanieu, A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050716a · Cited by 56 · see citing works

Rational design of novel, potent piperazinone and imidazolidinone BACE1 inhibitors.

Cumming, J., Le, T., Babu, S., Carroll, C., Chen, X., Favreau, L., Gaspari, P., Guo, T., Hobbs, D. W., Huang, Y., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.04.050 · Cited by 54 · see citing works

QM/MM As a Tool in Fragment Based Drug Discovery. A Cross-Docking, Rescoring Study of Kinase Inhibitors

Gleeson, M. P., & Gleeson, D. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900022h · Cited by 53 · see citing works

AllChem: generating and searching 1020 synthetically accessible structures

CRAMER, R. D. I., Soltanshahi, F., Jilek, R. J., & Campbell, B. (2007) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-006-9093-8 · Cited by 53 · see citing works

Piperazine sulfonamide BACE1 inhibitors: design, synthesis, and in vivo characterization.

Cumming, J., Babu, S., Huang, Y., Carrol, C., Chen, X., Favreau, L., Greenlee, W., Guo, T., Kennedy, M., Kuvelkar, R., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.03.050 · Cited by 50 · see citing works

A Database of Historically-Observed Chemical Replacements

Haubertin, D. Y., & Bruneau, P. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci600395u · Cited by 50 · see citing works

Cyclophilin inhibitors for the treatment of HCV infection.

Fischer, G. S., Gallay, P. A., & Hopkins, S. (2010) · PubMed · Cited by 46 · see citing works

Fragment-Based Drug Design: Computational and Experimental State of the Art

Hoffer, L., Renaud, J., & Horvath, D. (2011) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620711795767884 · Cited by 46 · see citing works

Scaffold Explorer: An Interactive Tool for Organizing and Mining Structure−Activity Data Spanning Multiple Chemotypes

Agrafiotis, D. K., & Wiener, J. J. M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1004495 · Cited by 46 · see citing works

In Silico Prediction of Drug Properties

Hutter, M. C. (2008) · Current Medicinal Chemistry · doi:10.2174/092986709787002736 · Cited by 45 · see citing works

Discovery of a novel HCV helicase inhibitor by a de novo drug design approach

Kandil, S., Biondaro, S., Vlachakis, D., Cummins, A.-C., Coluccia, A., Berry, C., Leyssen, P., Neyts, J. H., & Brancale, A. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.04.074 · Cited by 45 · see citing works

Mining a Chemical Database for Fragment Co-occurrence: Discovery of “Chemical Clichés”

Lameijer, E.-W., Kok, J. N., Bäck, T., & IJzerman, A. P. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci050370c · Cited by 44 · see citing works

Exploration of the Active Site of Neuronal Nitric Oxide Synthase by the Design and Synthesis of Pyrrolidinomethyl 2-Aminopyridine Derivatives

Ji, H., Delker, S. L., Li, H., Pavel Martasek, E., Roman, L. J., Poulos, T. L., & Silverman, R. B. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100947x · Cited by 44 · see citing works

Computational Fragment-Based Approach at PDB Scale by Protein Local Similarity

Moriaud, F., Doppelt‐Azeroual, O., Martin, L., Oguievetskaia, K., Koch, K., Vorotyntsev, A., Adcock, S. A., & Delfaud, F. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci8003094 · Cited by 43 · see citing works

Benzodioxoles: Novel Cannabinoid-1 Receptor Inverse Agonists for the Treatment of Obesity

Alig, L., Alsenz, J., Andjelković, M., Bendels, S., Benardeau, A. M., Bleicher, K., Bourson, A., David‐Pierson, P., Guba, W., Hildbrand, S., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701487t · Cited by 43 · see citing works

Design of a Fragment Library that maximally represents available chemical space

Schulz, M. N., Landström, J., Bright, K., & Hubbard, R. E. (2011) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9461-x · Cited by 42 · see citing works

Kinase Inhibitor Data Modeling and de Novo Inhibitor Design with Fragment Approaches

Vieth, M., Erickson, J. A., Wang, J., Webster, Y., Mader, M. M., Higgs, R. E., & Watson, I. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901147e · Cited by 41 · see citing works

Design and synthesis of new hydroxyethylamines as inhibitors of d-alanyl-d-lactate ligase (VanA) and d-alanyl-d-alanine ligase (DdlB)

Sova, M., Čadež, G., Turk, S., Majce, V., Polanc, S., Batson, S., Lloyd, A. J., Roper, D. I., Fishwick, C. W. G., & Gobec, S. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.034 · Cited by 40 · see citing works

Design, Synthesis, and Antifungal Activity of Novel Conformationally Restricted Triazole Derivatives

Wang, W., Sheng, C., Che, X., Ji, H., Miao, Z., Yao, J., & Zhang, W. (2009) · Archiv der Pharmazie · doi:10.1002/ardp.200900103 · Cited by 38 · see citing works

Novel conformationally restricted triazole derivatives with potent antifungal activity

Wang, W., Wang, S., Liu, Y., Dong, G., Cao, Y., Miao, Z., Yao, J., Zhang, W., & Sheng, C. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.09.070 · Cited by 38 · see citing works

Contributions of Computational Chemistry and Biophysical Techniques to Fragment-Based Drug Discovery

Gozalbes, R., Carbajo, R. J., & Pineda‐Lucena, A. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791111224 · Cited by 38 · see citing works

Discovery of highly potent novel antifungal azoles by structure-based rational design

Wang, W., Sheng, C., Che, X., Ji, H., Cao, Y., Miao, Z., Yao, J., & Zhang, W. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.07.144 · Cited by 38 · see citing works

Improved Model of Lanosterol 14α‐Demethylase by Ligand‐Supported Homology Modeling: Validation by Virtual Screening and Azole Optimization

Sheng, C., Wang, W., Che, X., Dong, G., Wang, S., Ji, H., Miao, Z., Yao, J., & Zhang, W. (2010) · ChemMedChem · doi:10.1002/cmdc.200900468 · Cited by 37 · see citing works

De Novo Parallel Design, Synthesis and Evaluation of Inhibitors against the Reverse Transcriptase of Human Immunodeficiency Virus Type-1 and Drug-Resistant Variants

Herschhorn, A., Lerman, L., Weitman, M., Gleenberg, I. O., Nudelman, A., & Hizi, A. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0613121 · Cited by 36 · see citing works

A new class of histamine H3 receptor antagonists derived from ligand based design

Roche, O., & Sarmiento, R. M. R. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.04.056 · Cited by 36 · see citing works

Tagged Fragment Method for Evolutionary Structure-Based De Novo Lead Generation and Optimization

Liu, Q., Masek, B. B., Smith, K. M., & Smith, J. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070750k · Cited by 35 · see citing works

Assessment of Molecular Similarity from the Analysis of Randomly Generated Structural Fragment Populations

Batista, J., Godden, J. W., & Bajorath, J. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci0601261 · Cited by 35 · see citing works

Structure-based rational design, synthesis and antifungal activity of oxime-containing azole derivatives

Xu, Y., Sheng, C., Wang, W., Che, X., Cao, Y., Dong, G., Wang, S., Ji, H., Miao, Z., Yao, J., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.03.014 · Cited by 34 · see citing works

Scaffold-Hopping Potential of Fragment-Based De Novo Design: The Chances and Limits of Variation

Krueger, B., Dietrich, A., Baringhaus, K. H., & Schneider, G. (2009) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620709788167971 · Cited by 34 · see citing works

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials

Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396 · see citing works

Discovery and development of natural product oridonin-inspired anticancer agents

Ding, Y., Ding, C., Ye, N., Liu, Z., Wold, E. A., Chen, H., Wild, C., Shen, Q., & Zhou, J. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.06.015 · Cited by 178 · see citing works

Equivariant 3D-conditional diffusion model for molecular linker design

Igashov, I., Stärk, H., Vignac, C., Schneuing, A., Satorras, V. G., Pascal Frossard, B., Welling, M., Bronstein, M. M., & Correia, B. E. (2024) · Nature Machine Intelligence · doi:10.1038/s42256-024-00815-9 · Cited by 169 · see citing works

SyntaLinker: automatic fragment linking with deep conditional transformer neural networks

Yang, Y., Zheng, S., Su, S., Zhao, C., Xu, J., & Chen, H. (2020) · Chemical Science · doi:10.1039/d0sc03126g · Cited by 149 · see citing works

Harnessing Allostery: A Novel Approach to Drug Discovery

Lu, S., Li, S., & Zhang, J. (2014) · Medicinal Research Reviews · doi:10.1002/med.21317 · Cited by 146 · see citing works

Deep Learning for Molecular Generation

Xu, Y., Lin, K., Wang, S., Wang, L., Cai, C., Song, C., Lai, L., & Pei, J. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0358 · Cited by 136 · see citing works

Computational Fragment-Based Drug Design: Current Trends, Strategies, and Applications

Bian, Y., & Xie, X.-Q. S. (2018) · The AAPS Journal · doi:10.1208/s12248-018-0216-7 · Cited by 102 · see citing works

DrugEx v3: scaffold-constrained drug design with graph transformer-based reinforcement learning

Liu, X., Ye, K., van Vlijmen, H., IJzerman, A. P., & van Westen, G. J. P. (2023) · Journal of Cheminformatics · doi:10.1186/s13321-023-00694-z · Cited by 91 · see citing works

Computer-aided drug design in anti-cancer drug discovery: What have we learnt and what is the way forward?

Iwaloye, O., Ottu, P. O., Olawale, F., Babalola, O. O., Elekofehinti, O. O., Kikiowo, B., Adegboyega, A. E., Ogbonna, H. N., Adeboboye, C. F., Folorunso, I. M., et al. (2023) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2023.101332 · Cited by 88 · see citing works

Discovery of Novel Inhibitors Targeting the Macrophage Migration Inhibitory Factor via Structure-Based Virtual Screening and Bioassays

Xu, L., Zhang, Y., Zheng, L. T., Qiao, C., Li, Y., Li, D., Zhen, X., & Hou, T. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401908w · Cited by 73 · see citing works

Systems Biology Brings New Dimensions for Structure-Based Drug Design

Pei, J., Yin, N., Ma, X., & Lai, L. (2014) · Journal of the American Chemical Society · doi:10.1021/ja504810z · Cited by 74 · see citing works

Group SELFIES: a robust fragment-based molecular string representation

Cheng, A., Cai, A., Miret, S., Malkomes, G., Phielipp, M., & Aspuru‐Guzik, A. (2023) · Digital Discovery · doi:10.1039/d3dd00012e · Cited by 70 · see citing works

MMP Inhibitors Past present and future

Cao, J. P. (2015) · Frontiers in bioscience · doi:10.2741/4365 · Cited by 66 · see citing works

Natural products in antiparasitic drug discovery: advances, opportunities and challenges

Shang, X., Dai, L., Cao, X., Ma, Y., Gulnaz, I., Miao, X., Li, X., & Yang, X. (2025) · Natural Product Reports · doi:10.1039/d5np00007f · Cited by 57 · see citing works

Chemical space of Escherichia coli dihydrofolate reductase inhibitors: New approaches for discovering novel drugs for old bugs

Srinivasan, B., Tonddast‐Navaei, S., Roy, A., Zhou, H., & Skolnick, J. (2018) · Medicinal Research Reviews · doi:10.1002/med.21538 · Cited by 46 · see citing works

Customizable de novo design strategies for DOCK: Application to HIVgp41 and other therapeutic targets

Allen, W. J., Fochtman, B. C., Balius, T. E., & Rizzo, R. C. (2017) · Journal of Computational Chemistry · doi:10.1002/jcc.25052 · Cited by 42 · see citing works

De novo design – hop(p)ing against hope

Schneider, G. (2012) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2012.06.001 · Cited by 39 · see citing works

Future De Novo Drug Design

Schneider, G. (2014) · Molecular Informatics · doi:10.1002/minf.201400034 · Cited by 36 · see citing works

Discovery of Novel KRAS-PDEδ Inhibitors by Fragment-Based Drug Design

Chen, L., Zhuang, C., Lu, J., Jiang, Y., & Sheng, C. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00057 · Cited by 33 · see citing works

De Novo Fragment Design for Drug Discovery and Chemical Biology

Rodrigues, T., Reker, D., Welin, M., Caldera, M., Brunner, C., Gabernet, G., Schneider, P., Walse, B., & Schneider, G. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201508055 · Cited by 33 · see citing works

Estimation of relative free energies of binding using pre‐computed ensembles based on the single‐step free energy perturbation and the site‐identification by Ligand competitive saturation approaches

Raman, E. P., Lakkaraju, S. K., Denny, R. A., & MacKerell, A. D. (2016) · Journal of Computational Chemistry · doi:10.1002/jcc.24522 · Cited by 32 · see citing works

Deep Learning Methods for Small Molecule Drug Discovery: A Survey

Hu, W., Liu, Y., Chen, X., Chai, W., Chen, H., Wang, H., & Wang, G. (2023) · IEEE Transactions on Artificial Intelligence · doi:10.1109/tai.2023.3251977 · Cited by 30 · see citing works

The design of novel inhibitors for treating cancer by targeting CDC25B through disruption of CDC25B-CDK2/Cyclin A interaction using computational approaches

Li, H., Ma, Y., Ma, Y., Li, Y., Chen, X., Dong, W., & Wang, R. (2017) · Oncotarget · doi:10.18632/oncotarget.16600 · Cited by 30 · see citing works

Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence

Moreira‐Filho, J. T., Silva, A. C., Dantas, R. F., Gomes, B. F., Neto, L. R. S., Brandão-Neto, J., Owens, R. J., Furnham, N., Neves, B. J., Silva, F. P., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642383 · Cited by 31 · see citing works

Drug Discovery in the Age of Artificial Intelligence: Transformative Target-Based Approaches

Patne, A., Dhulipala, S. M., Lawless, W., Prakash, S., Mohapatra, S., & Mohapatra, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212233 · Cited by 25 · see citing works

Computational Tools for In Silico Fragment-Based Drug Design

Mortier, J., Rakers, C., Frédérick, R., & Wolber, G. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612804547371 · Cited by 28 · see citing works

New drug approvals for 2022: Synthesis and clinical applications

Yuan, S., Shen, D., Jia, R., Sun, J., Song, J., & Liu, H. (2023) · Medicinal Research Reviews · doi:10.1002/med.21976 · Cited by 27 · see citing works

Spectrophores as one-dimensional descriptors calculated from three-dimensional atomic properties: applications ranging from scaffold hopping to multi-target virtual screening

Gladysz, R., dos Santos, F. M., Langenaeker, W., Thijs, G., Augustyns, K., & Winter, H. L. D. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0268-9 · Cited by 24 · see citing works

Best Practices for Docking-Based Virtual Screening

Neves, B. J., Mottin, M., Moreira‐Filho, J. T., Sousa, B. K. D. P., Mendonça, S. S., & Andrade, C. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822312-3.00001-1 · Cited by 24 · see citing works

Assessment of the Fragment Docking Program SEED

Goossens, K., Wroblowski, B., Langini, C., van Vlijmen, H., Caflisch, A., & Winter, H. L. D. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00556 · Cited by 21 · see citing works

Inspecting the Mechanism of Fragment Hits Binding on SARS‐CoV‐2 M pro by Using Supervised Molecular Dynamics (SuMD) Simulations

Bissaro, M., Bolcato, G., Pavan, M., Bassani, D., Sturlese, M., & Moro, S. (2021) · ChemMedChem · doi:10.1002/cmdc.202100156 · Cited by 19 · see citing works

Inhibition of HSP90 sensitizes a novel Raf/ERK dual inhibitor CY-9d in triple-negative breast cancer cells

Chen, Y., Wang, X., Cao, C., Wang, X., Liang, S., Peng, C., Fu, L., & He, G. (2017) · Oncotarget · doi:10.18632/oncotarget.22119 · Cited by 18 · see citing works

DigFrag as a digital fragmentation method used for artificial intelligence-based drug design

Yang, R., Zhou, H., Wang, F., & Yang, G. (2024) · Communications Chemistry · doi:10.1038/s42004-024-01346-5 · Cited by 16 · see citing works

Fragment-based design of SARS-CoV-2 Mpro inhibitors

Teli, D., Patel, B., & Chhabria, M. T. (2022) · Structural Chemistry · doi:10.1007/s11224-022-02031-w · Cited by 16 · see citing works

Topomer CoMFA and Virtual Screening Studies of Azaindole Class Renin Inhibitors

Xiang, Y., Song, J., & Zhang, Z. (2014) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207317666140107094708 · Cited by 16 · see citing works

Fragment-based screening by protein-detected NMR spectroscopy

Kerber, P. J., Nuñez, R., Jensen, D. R., Zhou, A. L., Peterson, F. C., Hill, R. B., Volkman, B. F., & Smith, B. C. (2023) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2023.06.018 · Cited by 15 · see citing works

Fragment-Based Drug Design: Strategic Advances and Lessons Learned

Chen, H., Zhou, X., Gao, Y., Chen, H., & Zhou, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12319-4 · Cited by 15 · see citing works

LEADS-FRAG: A Benchmark Data Set for Assessment of Fragment Docking Performance

Chachulski, L., & Windshügel, B. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00693 · Cited by 14 · see citing works

Considerations of Protein Subpockets in Fragment‐Based Drug Design

Bartolowits, M. D., & Davisson, V. J. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12631 · Cited by 13 · see citing works

Application of computational methods for class A GPCR Ligand discovery

Szwabowski, G. L., Baker, D. L., & Parrill, A. L. (2023) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2023.108434 · Cited by 13 · see citing works

Fragment-based strategy for structural optimization in combination with 3D-QSAR

Yuan, H., Tai, W., Hu, S., Liu, H., Zhang, Y., Yao, S., Ran, T., Lü, S., Ke, Z., Xiong, X., et al. (2013) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-013-9687-x · Cited by 13 · see citing works

De NovoDesign: From Models to Molecules

Schneider, G., & Baringhaus, K. H. (2013) · Wiley eBooks · doi:10.1002/9783527677016.ch1 · Cited by 13 · see citing works

GRELinker: A Graph-Based Generative Model for Molecular Linker Design with Reinforcement and Curriculum Learning

Zhang, H., Huang, J., Xie, J., Huang, W., Yang, Y., Xu, M., Lei, J., & Chen, H. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01700 · Cited by 13 · see citing works

Review of the impact of fragment-based drug design on PROTAC degrader discovery

Chen, P., Li, Q., & Lei, X. (2024) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2024.117539 · Cited by 12 · see citing works

From Computers to Bedside: Computational Chemistry Contributing to FDA Approval

Athanasiou, C., & Cournia, Z. (2018) · Methods and principles in medicinal chemistry · doi:10.1002/9783527806836.ch7 · Cited by 12 · see citing works

Advanced technologies for screening and identifying covalent inhibitors

Guo, Y., Wen, S., Tong, A., & Wang, Y. (2024) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2024.117833 · Cited by 11 · see citing works

Fragment based drug design and diversity-oriented synthesis of carboxylic acid isosteres

Ferri, M., Alunno, M., Greco, F. A., Mammoli, A., Saluti, G., Carotti, A., Sardella, R., Macchiarulo, A., Camaioni, E., & Liscio, P. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115731 · Cited by 11 · see citing works

Development and application of fragment-based de novo inhibitor design approaches against Plasmodium falciparum GST

Al-Qattan, M. N. M., & Mordi, M. N. (2023) · Journal of Molecular Modeling · doi:10.1007/s00894-023-05650-0 · Cited by 10 · see citing works

Identification of Marine-Derived SLC7A11 Inhibitors: Molecular Docking, Structure-Based Virtual Screening, Cytotoxicity Prediction, and Molecular Dynamics Simulation

Chen, J., Li, X., Tao, J., & Luo, L. (2024) · Marine Drugs · doi:10.3390/md22080375 · Cited by 9 · see citing works

Stalis: A Computational Method for Template‐Based Ab Initio Ligand Design

Lee, H. S., & Im, W. (2019) · Journal of Computational Chemistry · doi:10.1002/jcc.25813 · Cited by 8 · see citing works

TWN-FS method: A novel fragment screening method for drug discovery

Yoon, H. R., Park, G. J., Balupuri, A., & Kang, N. S. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.09.037 · Cited by 7 · see citing works

Polypharmacology: In Silico Methods of Ligand Design and Development

McKie, S. A. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2015-0006 · Cited by 7 · see citing works

Discovery of Novel and Highly Selective Cyclopropane ALK Inhibitors through a Fragment-Assisted, Structure-Based Drug Design

Fujimori, I., Wakabayashi, T., Murakami, M., Okabe, A., Ishii, T., McGrath, A. P., Zou, H., Saikatendu, K. S., & Imoto, H. (2020) · ACS Omega · doi:10.1021/acsomega.0c04900 · Cited by 6 · see citing works

History and Present Scenario of Computers in Pharmaceutical Research and Development

Saharan, V. A., Banerjee, S., Penuli, S., & Dobhal, S. (2022) · Springer eBooks · doi:10.1007/978-981-16-5180-9_1 · Cited by 6 · see citing works

De‐novo‐Fragmententwurf für die Wirkstoffforschung und chemische Biologie

Rodrigues, T., Reker, D., Welin, M., Caldera, M., Brunner, C., Gabernet, G., Schneider, P., Walse, B., & Schneider, G. (2015) · Angewandte Chemie · doi:10.1002/ange.201508055 · Cited by 5 · see citing works

#Nitrosocarbonyls 1: Antiviral Activity ofN-(4-Hydroxycyclohex-2-en-1-yl)quinoline-2-carboxamide against the Influenza A Virus H1N1

Al‐Saad, D., Memeo, M. G., & Quadrelli, P. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/472373 · Cited by 5 · see citing works

In Silico Drug Discovery and Design

Lill, M. A. (2013) · doi:10.4155/9781909453012 · Cited by 5 · see citing works

Fragment based drug design

Sachdeo, R. A., Anthwal, T., & Nain, S. (2022) · Physical Sciences Reviews · doi:10.1515/psr-2018-0162 · Cited by 5 · see citing works

Solvent-Site Prediction for Fragment Docking and Its Implication on Fragment-Based Drug Discovery

Rodriguez, L. A., Spanke, V. A., & Kersten, C. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c02352 · Cited by 4 · see citing works

Chemoinformatics

Babar, M., Hassan, F., Ijaz, M., & Mohyuddin, M. T. (2024) · Springer eBooks · doi:10.1007/978-981-97-0814-7_11 · Cited by 4 · see citing works

A Comprehensive Review on Integrated Approach for Discovery and Development of Novel Bioactive Compounds: From Natural Resources to Targeted Therapeutics

Piyushbhai, M. K., Sharma, P., Ramalingam, R., Binesh, A., & Venkatachalam, K. (2024) · Current Bioactive Compounds · doi:10.2174/0115734072327345241121185704 · Cited by 3 · see citing works

Fragment hopping protocol for the design of small-molecule protein–protein interaction inhibitors

Kell, S. R., Wang, Z., & Ji, H. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116879 · Cited by 3 · see citing works

From fragments to drugs: How AI and in silico methods accelerate fragment-to-lead optimization

Aledavood, E., Born, J., & Gil, C. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118997 · Cited by 3 · see citing works

Computational fragment-based drug design

Sliwoski, G. R., & Lowe, E. W. (2013) · doi:10.4155/ebo.13.335 · Cited by 2 · see citing works

Optimizing selective estrogen receptor degraders for anticancer drug development

Bhatia, N., Kumar, S., Goyal, L. D., & Thareja, S. (2025) · Future Medicinal Chemistry · doi:10.1080/17568919.2025.2467615 · Cited by 2 · see citing works

The activity regulation of lipase from Aspergillus fumigatus by ligand through allosteric exploration

Wang, F., Kang, K., Zhang, M., Fraser, K., Zhang, F., & Linhardt, R. J. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.138505 · Cited by 1 · see citing works

The rise of NMR-integrated fragment-based drug discovery in China

Li, Z., Wang, L., Gao, J., & Ruan, K. (2025) · Magnetic Resonance Letters · doi:10.1016/j.mrl.2025.200179 · Cited by 1 · see citing works

Advances in Docking-Based Drug Design for Microbial and Cancer Drug Targets

Gupta, D., & Khan, A. U. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822312-3.00020-5 · Cited by 1 · see citing works

Fragment-based Drug Discovery Strategy and its Application to the Design of SARS-CoV-2 Main Protease Inhibitor

Jiang, Y., Wu, Y., Wang, J., Ma, Y., Yu, H. L., & Wang, Z. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673294251240229070740 · Cited by 1 · see citing works

Delineando las tendencias temáticas en torno a la investigación de métodos computacionales en ciencias de la salud

Tapia, E. C. O., Bermejo-Sánchez, F. R., Noreña-Lucho, M. M., & Estrada-Choque, E. (2025) · Revista Cientifica de Sistemas e Informatica · doi:10.51252/rcsi.v5i1.913 · Cited by 1 · see citing works

Case Study 3: Fragment Hopping to Design Highly Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors

Ji, H., & Silverman, R. B. (2013) · Methods and principles in medicinal chemistry · doi:10.1002/9783527665143.ch18 · Cited by 1 · see citing works

Development and application of web-based open source drug discovery platforms

Pevzner, Y. (2015) · Digital Commons - University of South Florida (University of South Florida)

Development of a Bio-Molecular Fluorescent Probe Used in Kinetic Target-Guided Synthesis for the Identification of Inhibitors of Enzymatic and Protein-Protein Interaction Targets

Nacheva, K. P. (2012) · Digital Commons - University of South Florida (University of South Florida)

Activity-driven exploration of chemical space with morphing

Šícho, M., Svozil, D., & Hoksza, D. (2015) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2015.7359824

Development and application of Fragment-based De novo inhibitors against Plasmodium falciparum GSTPreprint

Al-Qattan, M. N. M., & Mordi, M. N. (2022) · Research Square · doi:10.21203/rs.3.rs-1477543/v1

Unified Guidance for Geometry-Conditioned Molecular GenerationPreprint

Ayadi, S., Hetzel, L., Sommer, J., Theis, F. J., & Günnemann, S. (2025) · Qeios · doi:10.32388/dq3y3t

Additional file 1 of DrugEx v3: scaffold-constrained drug design with graph transformer-based reinforcement learning

Liu, X., Ye, K., van Vlijmen, H. W. T., IJzerman, A. P., & van Westen, G. J. P. (2023) · Figshare · doi:10.6084/m9.figshare.22607542

Conception d'un logiciel pour la recherche de nouvelles molécules bioactives

Bournez, C. (2019) · doi:10.70675/1a4f06f0zdfa4z41efza87az70239c45c50c

Towards selecting the virtual series of molecules using the central fragment via R-FBDD at the early stages of drug discovery

Myazin, V. D., Shulga, D. A., Ivanov, N. N., & Palyulin, V. A. (2026) · Molecular Diversity · doi:10.1007/s11030-026-11620-4

Fragment-Based Design of Pesticide-Like Molecules: From Method Development to Agrochemical Discovery

Shi, X.-X., Wang, Z.-Z., Yang, R., Wang, F., & Yang, G. (2026) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6c00580

BindingDB Entry 50000629: Discovery of Novel KRAS-PDEδ Inhibitors by Fragment-Based Drug Design.

BindingDB (2019) · UC San Diego · doi:10.7270/q2cz39mm

BindingDB Entry 50044323: Discovery of novel inhibitors targeting the macrophage migration inhibitory factor via structure-based virtual screening and bioassays.

BindingDB (2015) · UC San Diego · doi:10.7270/q2qn68br

Computational Fragment-Based Drug Design

Sheng, C., Dong, G., & Wang, C. (2015) · Methods in pharmacology and toxicology · doi:10.1007/7653_2015_51 · Cited by 3 · see citing works

Current Status and Future Direction of Fragment-Based Drug Discovery: A Computational Chemistry Perspective

Wall, I. D., Hann, M. M., Leach, A. R., & Pickett, S. D. (2015) · Royal Society of Chemistry eBooks · doi:10.1039/9781782620938-00073 · Cited by 2 · see citing works

Computational Fragment-Based Drug Design: Current Trends, Strategies, and Applications

Bian, Y., & Xie, X.-Q. S. (2018) · The AAPS Journal · doi:10.1208/s12248-018-0216-7 · Cited by 102 · see citing works

Computational Medicinal Chemistry in Fragment-Based Drug Discovery: What, How and When

Rabal, O., Urbano‐Cuadrado, M., & Oyarzábal, J. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.277 · Cited by 19 · see citing works

The multiple roles of computational chemistry in fragment-based drug design

Law, R., Barker, O., Barker, J. J., Hesterkamp, T., Godemann, R., Andersen, O. A., Fryatt, T., Courtney, S., Hallett, D., & Whittaker, M. A. (2009) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-009-9284-1 · Cited by 57 · see citing works